NCT07520136

Brief Summary

Abstract Primary dysmenorrhea is a common gynecological condition affecting women of reproductive age and negatively impacting quality of life. It is characterized by cramping pain in the lower abdomen that may radiate to the lower back and thighs, leading to decreased daily functioning, academic performance, and psychological well-being. In addition to pharmacological treatments, complementary approaches are increasingly used in the management of dysmenorrhea. Yoga, a mind-body exercise that combines physical movement with mental focus, has been suggested as an effective method for reducing stress and pain associated with dysmenorrhea. The aim of this study is to evaluate the level of awareness about dysmenorrhea in young women with primary dysmenorrhea and to investigate the effects of a yoga program on pain, quality of life, and menstrual attitudes following an educational session provided to all participants. Pain severity, quality of life, and menstrual attitudes will be assessed using validated questionnaires and scales, including the Visual Analog Scale (VAS), awareness questionnaire, functional and emotional dysmenorrhea scale, Menstrual Attitude Scale, and quality of life questionnaire. This study aims to determine whether yoga exercises reduce dysmenorrhea symptoms and improve quality of life in young women with primary dysmenorrhea. Additionally, the study is expected to increase awareness about dysmenorrhea and provide evidence for the effectiveness of yoga as a non-pharmacological intervention.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Apr 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Apr 2026Nov 2026

First Submitted

Initial submission to the registry

March 30, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 9, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

April 9, 2026

Status Verified

April 1, 2026

Enrollment Period

4 months

First QC Date

March 30, 2026

Last Update Submit

April 2, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS) before and after the intervention.

    Baseline and after 8 weeks of intervention

Study Arms (2)

Yoga Group

EXPERIMENTAL
Other: Yoga Exercise Program

control grup

NO INTERVENTION

Interventions

Participants in the intervention group will receive a structured yoga exercise program. The yoga program will include breathing exercises, relaxation techniques, and selected yoga postures targeting the pelvic region. The exercises will be performed regularly for the duration of the study. Pain intensity, quality of life, and menstrual attitudes will be evaluated before and after the intervention.

Yoga Group

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy young women with primary dysmenorrhea
  • Aged between 18-25 years
  • Having a regular menstrual cycle (30-35 days)
  • Menstrual bleeding duration of 3-10 days

You may not qualify if:

  • Having secondary dysmenorrhea
  • Participation in regular physical activity or other exercise programs
  • Use of medication
  • Diagnosed with polycystic ovary syndrome
  • Having bleeding disorders
  • Positive pregnancy test
  • Being in the breastfeeding period
  • Primary dysmenorrhea attributed to medical disorders or other causes
  • Participants who miss three consecutive sessions or four alternating sessions during the study will be excluded from the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, PhD

Study Record Dates

First Submitted

March 30, 2026

First Posted

April 9, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

April 9, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share